Director Delta John buys 5,000 MSGM shares in 2 tranches for $13,020.00 amid -47.8% 30-day decline
Delta John purchased 5,000 shares across two transactions on 2025-12-11 and 2025-12-12 at a blended average price of $2.60, increasing his holdings from 7,000 to 12,000 shares (+71.4%). This buying activity occurs at a particularly depressed price point: the current market price of $2.55 is 47.8% below the 52-week high of $4.88, matching the stock's 30-day decline. However, the insider's prior trading patterns at MSGM show mixed outcomes—his two preceding purchases at this ticker yielded a 30-day return of -0.7% and 90-day return of -4.8%, alongside another buy with -4.5% 30-day but +7.4% 90-day returns—suggesting inconsistent timing when buying MSGM shares. The company posted $3.1M quarterly revenue with positive net income of $789.3K and +25.7% annual revenue growth, yet was unprofitable on a full-year basis, creating fundamental ambiguity about the investment thesis behind this accumulation.
Director Delta John buys 7,000 shares at $2.92 average (2 transactions); stock now $2.80, down 26.7% in 30 days.
Delta John purchased 7,000 shares across 2 separate transactions totaling $20,426.00 at a blended average price of $2.92, establishing an initial position where none existed. The current price of $2.80 is 4.1% below his average purchase price and the stock has declined 26.7% over the past 30 days from its recent levels. While the company posted net income of $4,258,400.00 and annual revenue growth of 25.7%, it remains unprofitable on a full-year basis, creating mixed signals about underlying operational health. The director's entry into the stock amid recent weakness and against a backdrop of near-term negative momentum presents context for investor scrutiny of his motivation and thesis.
